CRBP logo

CRBP
Corbus Pharmaceuticals Holdings Inc

21,451
Mkt Cap
$179.74M
Volume
261,229.00
52W High
$20.56
52W Low
$4.64
PE Ratio
-1.86
CRBP Fundamentals
Price
$10.24
Prev Close
$10.69
Open
$10.65
50D MA
$13.53
Beta
1.37
Avg. Volume
412,822.74
EPS (Annual)
-$3.68
P/B
1.39
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Analysts
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven ratings firms that are covering the stock, Marketbeat...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Analysts
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven ratings firms that are covering the stock, Marketbeat...
MarketBeat·2d ago
News Placeholder
B. Riley Forecasts Lower Earnings for Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Equities researchers at B. Riley dropped their FY2025 earnings per share estimates for Corbus Pharmaceuticals in a report released...
MarketBeat·5d ago
News Placeholder
What is B. Riley's Forecast for CRBP FY2029 Earnings?
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Research analysts at B. Riley issued their FY2029 EPS estimates for Corbus Pharmaceuticals in a research note issued to investors...
MarketBeat·8d ago
News Placeholder
Research Analysts Issue Forecasts for CRBP Q1 Earnings
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings estimates for Corbus Pharmaceuticals in a research note issued to investors...
MarketBeat·21d ago
News Placeholder
Royal Bank Of Canada Lowers Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $53.00
Royal Bank Of Canada reduced their target price on shares of Corbus Pharmaceuticals from $55.00 to $53.00 and set an "outperform" rating on the stock in a research report on Thursday...
MarketBeat·22d ago
News Placeholder
Corbus Pharmaceuticals (NASDAQ:CRBP) Announces Earnings Results, Misses Expectations By $0.10 EPS
Corbus Pharmaceuticals (NASDAQ:CRBP - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($1.90) EPS for the quarter, missing the consensus...
MarketBeat·23d ago
News Placeholder
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Average Rating of "Moderate Buy" by Brokerages
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven brokerages that are covering the stock, MarketBeat Ratings...
MarketBeat·27d ago
News Placeholder
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
Zacks·4mo ago
News Placeholder
Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?
Zacks·7mo ago

Latest CRBP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.